A new report from a marijuana consumer advocacy organization details the average spending of consumers in the sector and shows more women are active in cannabis than men.
The Cannabis Consumer Coalition, a US-based watchdog of the emerging industry, seeks to inform would-be consumers on the benefits and precautions to take with cannabis.
Their latest study –called “2017 Report on Cannabis Consumer Demographics and Consumption Habits”–polls 537 consumers and helps paint a clearer image of what marijuana consumers may look like today. Participants of the study were broken into income tiers,  with 20 percent making up lower income households. Overall, 35 percent represent those who make between $26,000 and $55,000.


US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 


“The report also discovered that 27 percent have combined incomes over $75,000 and that they are professionals from all walks of life,” as Civilized reports. According to the online publication, the average cannabis consumer spends close to $600 a year, while a premium tier of consumer exists that can spend more than $300 a month on the various products available.
“Nineteen percent spend $100 a month and 21 percent fork over $200 a month for marijuana. Premium customers spend over $300 a month on cannabis products,” the report reads.

Cannabis consumers could reach $24-billion in sales

Larisa Bolivar, author of the report, told Civilized that based on a poll from 2016, 13 percent of Americans claim to consume on a regular basis, equating to roughly 41 potential customers.
“If these consumers spend the minimum amount of $600 a year, that equates to $24-billion in marijuana sales,” said Bolivar
Another key factor that makes this report stand out, per Forbes, is the fact that women have a larger part of the sector than previously noted in other market reports.
“The most profound finding in our report was that that majority of respondents were women by over a 15 percent margin,” said Bolivar.
The coalition’s report found women represented 53 percent of the cannabis consumers, while men stood for 42 percent.
This highlights a division with similar reports that more commonly show men as the predominant users. Last year Headset, a cannabis tech company conducting market reports, released a cannabis consumer report that indicated 68.9 percent of the market represented men, while 31.1 percent was women.
“This disparity is not surprising given cannabis culture’s emphasis on the male pothead. Next, we examined the distribution of customer age,” the report said.

Investor Takeaway

Indeed, the cannabis market is only going to garner more traction from here. By 2025, the sector is expected to be worth roughly $24 billion–up from $6.5 billion in 2016.
As the cannabis market continues its boom, conventions and traditions from other sectors are making their way into this one. It’s always beneficial for companies and investors to gain a clearer picture of the consumers and their preferences.
Don’t forget to follow us @INN_LifeScience for real-time news updates.
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to provide a corporate update on its psychedelic pharmaceuticals program. Since its inception, the Company has built a unique product pipeline for novel uses of ketamine, psilocybin and undisclosed psychedelics. PharmaTher is positioning itself to partner its psilocybin program and panaceAI™, and focus on advancing its novel ketamine product pipeline in Parkinson’s disease, depression and pain via the U.S. Food and Drug Administration (“FDA”) regulatory pathway.

“We have made tremendous progress over the last several months that saw our product pipeline evolve to focus on the massive opportunity and potential of ketamine, an FDA approved drug with a known safety profile, to treat significant unmet medical needs for Parkinson’s disease, depression and pain,” said Fabio Chianelli, CEO of PharmaTher. “With our focus on ketamine through repurposing, combining it with an FDA approved drug and delivering it with our novel microneedle delivery system, we are now positioned to expedite our clinical development objectives by taking advantage of the FDA’s 505(b)(2) regulatory pathway and commercializing disruptive ketamine treatments for mental health and pain disorders.”

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB)(TSX: ACB), and Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED).

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or “Progressive Planet”), an emerging leader in reducing the carbon footprint of cement products using natural pozzolans, is pleased to announce it has sold and optioned a combined total of 10 million of its 10.5 million shares of Snow Lake Resources.

The sale and option agreements were made with two arms-length purchasers. The first sale was for 1,700,000 shares at $0.04 per share for a total of $68,000 and includes an option granted by PLAN entitling the same party to purchase an additional 4,966,666 shares at $0.04 per share until May 11, 2021 . The second sale was for 1,250,000 shares at $0.04 per share for a total of $50,000 and includes an option granted by PLAN to such party to purchase an additional 2,083,334 shares until August 14, 2021 . As at the date of this news release, PLAN has received $116,000 and will receive another $284,000 if the remaining shares are purchased under the option agreements.

Keep reading... Show less

First Products to Hit California Shelves in Q2 2021

 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that its fully funded state of the art 185,000 square foot production facility in Commerce, California is nearing completion and will be ready to serve the $3b California cannabis market in Q2 2021. The project is on target to be completed in April 2021 with the Company planning for the first of its full line of edibles, tinctures and vape products to be on California retail shelves by May.

Keep reading... Show less

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders – potential industry partners, shareholders and prospective investors – by increasing awareness of its remarkable natural mustard-derived crop protection products.

TODAY: The Future of Food Investment Conference – SnowCap Ventures
Tuesday, Nov. 24th at 1:50 pm ET
Investors Register Here

Keep reading... Show less